TABLE 1.
Baseline characteristics.
| Characteristics | All (n = 23) | rhTPO group (n = 14) | Control group (n = 9) | p |
|---|---|---|---|---|
| Age (years) | 50 (18–72) | 59 (18–72) | 49 (21–70) | 0.403 |
| Gender (male/female) | 11/12 | 8/6 | 3/6 | 0.491 |
| Severity | 0.572 | |||
| SAA | 15 | 8 | 7 | |
| VSAA | 8 | 6 | 2 | |
| Immunosuppressor | 0.205 | |||
| IST | 10 | 6 | 4 | |
| CsA | 13 | 8 | 5 | |
| At diagnosis a | ||||
| Hb (g/L) | 69.5 (58.75, 83) | 65 (40, 85) | 0.892 | |
| PLT (×109/L) | 14.5 (8.75, 19.75) | 37 (12.5, 47.5) | 0.120 | |
| ANC (×109/L) | 0.625 (0.14, 3.11) | 0.7 (0.25, 2.35) | 0.862 | |
| Ret (×109/L) | 21.95 (9.25, 63.4) | 24.85 (13.65, 65) | 0.640 |
a
Peripheral blood cell counts at diagnosis are presented as median (range). Ret, absolute reticulocyte count.